Literature DB >> 17896980

Neurotrophic factors--a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases?

O Schulte-Herbrüggen1, A Braun, S Rochlitzer, M C Jockers-Scherübl, R Hellweg.   

Abstract

Nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) belong to the protein family of neurotrophins. They both display profound neuromodulatory functions and are essentially involved in the survival and homeostatic maintenance of central and peripheral neurons during development and adulthood. Moreover, NGF and BDNF are known to modulate immune cell function and thus serve as mediators in the reciprocal cross talk between neurons and immune cells. Neurotrophic factors have been implicated in pathophysiological mechanisms of many diseases of the nervous and the immune system, such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), neuropathy, pain, allergic bronchial asthma (BA) and neurotrophic keratitis. For all these diseases research has reached the point of creating strategies for therapeutic intervention with neurotrophins. In this review, we present an overview of the pathophysiology, therapeutic interventions and strategies concerning NGF and BDNF in the mentioned diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17896980     DOI: 10.2174/092986707781745578

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  30 in total

1.  Serum brain-derived neurotrophic factor and peripheral indicators of the serotonin system in underweight and weight-recovered adolescent girls and women with anorexia nervosa.

Authors:  Stefan Ehrlich; Harriet Salbach-Andrae; Sarah Eckart; Julia V Merle; Roland Burghardt; Ernst Pfeiffer; Leonora Franke; Ralf Uebelhack; Ulrike Lehmkuhl; Rainer Hellweg
Journal:  J Psychiatry Neurosci       Date:  2009-07       Impact factor: 6.186

2.  Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid.

Authors:  Siva Ram Kiran Vaka; S Narasimha Murthy; Michael A Repka; Tamas Nagy
Journal:  J Pharm Sci       Date:  2011-03-01       Impact factor: 3.534

3.  The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension.

Authors:  Zoya Marinova; Susanne Walitza; Edna Grünblatt
Journal:  J Neural Transm (Vienna)       Date:  2017-03-18       Impact factor: 3.575

4.  Cord blood immune biomarkers in small for gestational age births.

Authors:  N Matoba; F Ouyang; K K L Mestan; N F M Porta; C M Pearson; K M Ortiz; H C Bauchner; B S Zuckerman; X Wang
Journal:  J Dev Orig Health Dis       Date:  2011-04       Impact factor: 2.401

Review 5.  New strategies in the management of Guillain-Barré syndrome.

Authors:  Jinting Xiao; Alain R Simard; Fu-Dong Shi; Junwei Hao
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

6.  Delivery of brain-derived neurotrophic factor via nose-to-brain pathway.

Authors:  Siva Ram Kiran Vaka; Sathyanarayana Narasimha Murthy; Anna Balaji; Michael A Repka
Journal:  Pharm Res       Date:  2011-08-31       Impact factor: 4.200

7.  Apoptosis and in vitro Alzheimer disease neuronal models.

Authors:  P Calissano; C Matrone; G Amadoro
Journal:  Commun Integr Biol       Date:  2009

8.  Tuning and fine-tuning of synapses with adenosine.

Authors:  A M Sebastião; J A Ribeiro
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

9.  The role of adenosine in Alzheimer's disease.

Authors:  Anisur Rahman
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 10.  Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotection.

Authors:  Ana M Sebastião; Joaquim A Ribeiro
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.